Screening for peripheral artery disease using the ankle-brachial index: updated evidence report and systematic review for the US preventive services task force JAMA, 320 (2) (2018), pp. 184-196 CrossrefView in ScopusGoogle Scholar [23] B. Williams, et al. ESC/ESH guidelines for the manageme...
Data support the use of atherectomy as effective in the peripheral vessels in patients who meet the following criteria: have symptomatic peripheral vascular disease (limb-threatening ischemia or functionally limiting claudication); and cannot be treated by standard angioplasty techniques alone, i.e., ...
Figure 2. Changes in the five year incidence of (A,B) lower extremity amputation (LEA) and (C,D) hospitalisation for heart failure (HHF) in patients with (A,C) or without (B,D) peripheral artery disease (PAD) after initiation of sodium glucose cotransporter 2 inhibitor (SGLT2i) and ...
Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. Can J Cardiol. 2015;31(3):287-295. doi:10.1016/j.cjca.2014.11.002 PubMedGoogle ScholarCrossref 57. Ger TY, Fu Y, Chi CC...
Whether sodium glucose co-transporter 2 inhibitors (SGLT2i) are associated with a lower risk of cardiovascular as well as adverse lower limb events in patients with type-2 diabetes mellitus (T2DM) and concomitant peripheral artery disease (PAD) is unclear. We aimed to evaluate the risk of card...
First, the traditional CHA2DS2-VASc score of all patients was calculated by summing up the abnormalities defined based on whether the patients fulfilled one or more of the following criteria: CHF defined via chart review; ICD-10 code diagnosis; echocardiographic ejection fraction; HTN with a systo...
Firstly, a commonplace limitation of using a claim-based registry database is the inaccuracy that is brought about by identifying patients based only on diagnostic codes, instead of standardized criteria that are used in clinical trials. Although the claims of disease-specific treatment might be ...
1. Introduction Walking impairment is the main clinical concern in patients with symptomatic pe- ripheral artery disease (PAD). In these patients, walking impairment has been associated with increased barriers to physical activity practice [1], reduced physical activity levels [2], impaired ...
Melatonin secretion is inhibited by exposure to light at short wavelengths, a deregulation in its secretion was noted in many disease processes, including cancer [32,33]. Shift workers experience light exposure and sleep deprivation during night shifts, which results in reduced levels of melatonin [...
Firstly, a commonplace limitation of using a claim-based registry database is the inaccuracy that is brought about by identifying patients based only on diagnostic codes, instead of standardized criteria that are used in clinical trials. Although the claims of disease-specific treatment might be ...